Advances, challenges and growing frustration.
D000163:Acquired Immunodeficiency Syndrome; D000998:Antiviral Agents / Q000627:therapeutic use; D002100:Cachexia / Q000150:complications / Q000188:drug therapy; D000077404:Cidofovir; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016527:Drug Costs; D004359:Drug Therapy, Combination; D013006:Growth Hormone / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D054303:HIV Reverse Transcriptase; D015497:HIV-1 / Q000201:enzymology; D006801:Humans; D007111:Immunity, Cellular; D018445:Infectious Disease Transmission, Vertical; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D011057:Politics; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D003596:Cytosine; D013006:Growth Hormone; D054303:HIV Reverse Transcriptase; D000077404:Cidofovir